Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection

被引:11
作者
Domenig, C
Traunmüller, F
Kozek, S
Wisser, W
Klepetko, W
Steininger, R
Spiss, C
Thalhammer, F
机构
[1] Univ Hosp Vienna, Div Transplantat, Dept Surg, A-1090 Vienna, Austria
[2] Univ Hosp Vienna, Dept Internal Med 1, Div Infect Dis, A-1090 Vienna, Austria
[3] Univ Hosp Vienna, Dept Anesthesiol & Gen Intens Care, A-1090 Vienna, Austria
[4] Univ Hosp Vienna, Dept Surg, Div Cardiothorac Surg, A-1090 Vienna, Austria
关键词
D O I
10.1097/00007890-200103270-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. It is well known that the bactericidal effect of beta -lactam antibiotics is closely related to the time which the serum concentration of the antibiotic remains above the minimal inhibitory concentration of the target pathogen. Thus, the optimal administration of beta -lactam antibiotics would be the continuous infusion of the drug. Methods. me present a case report with a critically ill double-lung transplanted patient with pneumonia due to a multidrug- resistant Pseudomonas aeruginosa who received continuously 8 g meropenem/24 hr. Based on a previous pharmacokinetic study showing that continuous infusion of meropenem is at least equivalent to intermittent administration this case report is reported to demonstrate the clinical efficacy of continuous infusion. Results. C-reactive protein and pneumonia decreased rapidly when clinical conditions were improved significantly, Continuous administration of meropenem did not interfere with cyclosporine, no side effects were seen, and the patient's renal function was not impaired during the whole period of treatment. Conclusion. The continuous administration of beta -lactam antibiotics is a powerful application in critically ill patients to intensify antimicrobial therapy.
引用
收藏
页码:744 / 745
页数:2
相关论文
共 10 条
[1]   Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections [J].
Benko, AS ;
Cappelletty, DM ;
Kruse, JA ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :691-695
[2]  
Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63
[3]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[4]   CONTINUOUS-INFUSION OF CEFTAZIDIME IN FEBRILE NEUTROPENIC PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
DAENEN, S ;
ERJAVEC, Z ;
UGES, DRA ;
DEVRIESHOSPERS, HG ;
DEJONGE, P ;
HALIE, MR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (03) :188-192
[5]   ROLE OF PHARMACOKINETICS IN THE OUTCOME OF INFECTIONS [J].
DRUSANO, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :289-297
[6]   Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections [J].
James, JK ;
Palmer, SM ;
Levine, DP ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :696-700
[7]  
JOYNT GM, 1999, CRITICAL CARE S1, V3, P36
[8]   Serum bactericidal activity of ceftazidime: Continuous infusion versus intermittent injections [J].
Nicolau, DP ;
Nightingale, CH ;
Banevicius, MA ;
Fu, Q ;
Quintilliani, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :61-64
[9]  
SORIANO F, 1992, J ANTIMICROB CHEMOTH, V30, P566
[10]   Continuous infusion versus intermittent administration of meropenem in critically ill patients [J].
Thalhammer, F ;
Traunmüller, F ;
El Menyawi, I ;
Frass, M ;
Hollenstein, UM ;
Locker, GJ ;
Stoiser, B ;
Staudinger, T ;
Thalhammer-Scherrer, R ;
Burgmann, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :523-527